Clinical phase II/III trial of Ustekinumab to treat type 1 diabetes.
Principal Investigator
Locations
BC Diabetes | Vancouver,British Columbia
Mount Sinai Hospital | Toronto,Ontario
Study Code
ITN832AI
Study Status
Follow-up
(Scroll Down for More)
BC Diabetes | Vancouver,British Columbia
Mount Sinai Hospital | Toronto,Ontario
ITN832AI
Follow-up